menu
    • menu

    Company profile for SMS Pharmaceuticals

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed ...
    SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SMS Pharmaceuticalsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Regd.off : Plot No:19-III, Road No:71, Jubilee Hills,Opp.Bharatiya Vidya Bhava...
    Telephone
    Telephone
    91 - 40 - 6628 8888
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://smspharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 4916

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    BMS, J&J, Bayer lead 25,000+ pharma layoffs in 2024; Amylyx, FibroGen, Kronos Bio hit by trial failures, cash crunch

    BMS, J&J, Bayer lead 25,000+ pharma layoffs in 2024; Amylyx, FibroGen, Kronos Bio hit by trial failures, cash crunch

    Since 2022, there has been a significant surge in layoffs by pharmaceutical and biotech companies. While this trend continued into 2024, the industry showed signs of stabilization in the last four months of the year with the pace of layoffs slowing down. Nonetheless, 2024 was a challenging year. Data compiled by PharmaCompass indicates that over 25,000 layoffs were announced in 2024, driven by economic pressures, failed clinical trials, and strategic pivots. Bristol Myers Squibb and Johnson & Johnson led the layoffs with about 2,300 job cuts each. Bayer announced elimination of 1,800 positions.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available) US, Europe, China bear brunt of job cuts; Big Pharma hands pink slips to 10,000 Over 190 biopharma companies announced layoffs in 2024. The year began on a grim note — 27 firms announced significant job cuts in January 2024. By the yearend, Big Pharma alone had contributed more than 10,000 layoffs to the year’s total of over 25,000. Novartis announced over 1,200 job cuts in 2024. It eliminated 330 jobs after it acquired German biotech MorphoSys through the closure of sites in Munich and Boston. Similarly, Bayer announced significant reductions at its US and Swiss facilities.  North America saw increased retrenchments, especially at biotech hubs such as Boston, San Diego, and New Jersey. Massachusetts, with Boston and Cambridge as the epicenter of US biotechnology, saw around 4,000 layoffs, with companies like Relay Therapeutics, Editas Medicine, and Takeda driving the numbers. In San Diego, workforce reductions by Takeda, and Bavarian Nordic collectively resulted in over 900 job losses, significantly impacting the local biotech ecosystem. New Jersey was subject to broader restructuring efforts with BMS and Bayer contributing nearly 1,500 layoffs. The impact in Europe was equally severe. Germany, home to some of the world’s largest pharmaceutical companies, saw over 2,500 layoffs as Bayer and Boehringer Ingelheim scaled back operations. Novartis’ decision to shut down its Munich site added hundreds more to the tally. In Switzerland, Idorsia eliminated 270 positions. Dutch biotech UniQure reduced its workforce by 65 percent (around 300 jobs). That included the sale of a Massachusetts manufacturing facility to Genezen. Denmark also felt the strain, with Leo Pharma cutting 250 roles as part of a strategic revamp. China emerged as another focal point of workforce reductions in 2024. Global pharmaceutical giants, such as Merck and Johnson & Johnson, restructured their operations in response to market complexities in the region. Local companies such as Connect Biopharma, which is transitioning to a US-focused company, also scaled back their presence in the country.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Amylyx, FibroGen, Lyra, Athira drastically reduce staff over setbacks in clinical trials Clinical trial failures were one of the most significant drivers of layoffs in 2024. For instance, Amylyx Pharmaceuticals faced a devastating blow when its amyotrophic lateral sclerosis (ALS) therapy, Relyvrio, failed a confirmatory trial. This led to a 70 percent reduction in its workforce, leaving only 100 employees from the 384 full-time staff reported at the end of 2023. The company’s decision to pull the therapy from the market compounded the layoffs. BioMarin Pharmaceutical had to reduce its workforce, as it streamlined its pipeline in response to trial challenges. In August, the company announced a reduction of 225 employees, citing “organizational redesign efforts”. These layoffs followed 170 redundancies announced earlier in May. FibroGen, once considered a leader in oncology drug development, was among the most heavily impacted. The high-profile failure of its anti-CTGF antibody in two late-stage cancer trials led to the discontinuation of its lead candidate, resulting in a 75 percent reduction in its US workforce. Lyra Therapeutics also implemented a 75 percent workforce reduction, affecting 87 employees, after its chronic rhinosinusitis program struggled. Similarly, Athira Pharma cut 70 percent of its team after its Alzheimer’s candidate failed a phase 2/3 trial.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Cash crunch, mergers compel Kronos Bio, Editas, Vincerx, Gilead to downsize In addition to clinical failures, funding constraints played a pivotal role in reshaping the biotech landscape. Kronos Bio stood out as one of the hardest-hit firms, cutting 21 percent and 83 percent of its existing workforce in March and November, respectively, as it sought to divest assets and conserve cash. Editas Medicine’s inability to secure partnerships for its sickle cell program forced the company to revert to preclinical research, resulting in a 65 percent workforce reduction. The trend of scaling back R&D pipelines was particularly evident among biotechs struggling to advance preclinical programs to clinical trials. Boundless Bio and Senti Bio exemplified this, choosing to focus on a handful of promising candidates, while reducing discovery efforts. Consolidation often results in overlapping roles, leading to inevitable workforce reductions. Apart from the MorphoSys layoffs by Novartis, Vincerx Pharma faced job losses after it got acquired by Oqory (a clinical-stage ADC company). Vincerx had to cut its workforce by 55 percent.  Amid ongoing reorganization efforts, Gilead closed its Seattle, Washington (US), office and laid off 72 employees of its subsidiary Kite Pharma. Gilead also announced that its Kite facility in Philadelphia, Pennsylvania (US), would close by mid-2025. That was followed by 104 additional layoffs at its California headquarters. In April, it had cut 58 jobs in California. Gilead also announced that its Kite facility in Philadelphia would close by mid-2025. Vir Biotechnology reduced its workforce by 25 percent (i.e. 140 layoffs) to focus on its hepatitis program, and GlycoMimetics let go of 80 percent of its workforce after the FDA demanded an additional clinical trial for its leukemia treatment. Meanwhile, Lexicon Pharmaceuticals reduced its workforce by 60 percent after it stopped commercial operations and transitioned back to being a clinical stage company.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Our view It takes decades to build innovation ecosystems. The concentration of layoffs in major biotech hubs has raised concerns about the potential long-term impact on these ecosystems. In 2025, the key challenge will be to maintain the momentum of innovation, as organizations operate with a leaner workforce and a more focused pipeline.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 4560

    https://www.pharmacompass.com/radio-compass-blog/bms-j-j-bayer-lead-25-000-pharma-layoffs-in-2024-amylyx-fibrogen-kronos-bio-hit-by-trial-failures-cash-crunch

    #PharmaFlow by PHARMACOMPASS
    16 Jan 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    SMS Pharmaceuticals reports robust Q2FY24 operational performance
    SMS Pharmaceuticals reports robust Q2FY24 operational performance

    10 Nov 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/sms-pharmaceuticals-reports-robust-q2fy24-operational-performance-14883

    INDIAN PHARMA POST
    10 Nov 2023
    Share Share
    SMS Pharma Q1 net profit rises 153% at Rs. 23.6 crore
    SMS Pharma Q1 net profit rises 153% at Rs. 23.6 crore

    09 Aug 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=140678&sid=2

    PHARMABIZ
    09 Aug 2021
    Share Share
    GSK to recall Ranitidine from India after regulator alert
    GSK to recall Ranitidine from India after regulator alert

    26 Sep 2019

    // THEECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gsk-to-recall-ranitidine-from-india-after-regulator-alert/articleshow/71303923.cms

    THEECONOMICTIMES
    26 Sep 2019
    Share Share
    SMS Pharma gets USFDA nod for Andhra unit
    SMS Pharma gets USFDA nod for Andhra unit

    25 Dec 2015

    // BUSINESS LINE

    http://www.thehindubusinessline.com/companies/sms-pharma-gets-usfda-nod-for-andhra-unit/article8025982.ece

    BUSINESS LINE
    25 Dec 2015
    Share Share
    SMS Pharma extends rally post stock split; hit new high
    SMS Pharma extends rally post stock split; hit new high

    17 Dec 2015

    // BUSINESS STANDARD

    http://www.business-standard.com/article/markets/sms-pharma-extends-rally-post-stock-split-hit-new-high-115121800184_1.html

    BUSINESS STANDARD
    17 Dec 2015
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Famotidine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Famotidine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-01-14

    Pay. Date : 2013-08-30

    DMF Number : 21442

    Submission : 2008-03-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2022-480 - Rev 00

    Issue Date : 2023-04-04

    Type : Chemical

    Substance Number : 1012

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 226MF10116

    Registrant's Address : Plot No. 72, H. No.:8-2-334/3&4 Road No. 5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad, Telangana, India

    Initial Date of Registration : 2014-06-18

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2019-06-26

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0071

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-0021

    Start Marketing Date : 2020-06-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Rizatriptan Benzoate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Rizatriptan Benzoate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-10-18

    Pay. Date : 2013-05-24

    DMF Number : 23066

    Submission : 2009-08-26

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-028 - Rev 00

    Issue Date : 2020-05-18

    Type : Chemical

    Substance Number : 2585

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 228MF10019

    Registrant's Address : Plot No. 72, H. No.8-2-334/3&4 Road No. 5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad, Telangana, India

    Initial Date of Registration : 2016-01-14

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2019-06-26

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0071

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-5016

    Start Marketing Date : 2009-05-13

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Tadalafil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Tadalafil

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-12-04

    Pay. Date : 2014-11-13

    DMF Number : 24206

    Submission : 2010-09-28

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2014-308 - Rev 01

    Issue Date : 2024-09-18

    Type : Chemical

    Substance Number : 2606

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 231MF10041

    Registrant's Address : Plot No. 72, H. No.8-2-334/3&4 Road No. 5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad, Telangana, India

    Initial Date of Registration : 2019-02-13

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2019-06-26

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0071

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-0030

    Start Marketing Date : 2024-06-14

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pami Future Co., Ltd.

    Registration Date : 2024-03-22

    Registration Number : 20240322-203-I-667-18

    Manufacturer Name : SMS Pharmaceuticals Limited 　

    Manufacturer Address : Unit-II, Plot No. 24 & 24B and 36 & 37, SV Co-Operative Industrial Estate, Bachupally, Medchal-Malkajgiri District, Hyderabad, Telangana – 500090, INDIA.

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Lamotrigine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Lamotrigine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-10-24

    Pay. Date : 2023-09-26

    DMF Number : 34290

    Submission : 2019-11-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2020-222 - Rev 01

    Issue Date : 2023-11-27

    Type : Chemical

    Substance Number : 1756

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-08

    Valid Till : 2025-07-21

    Written Confirmation Number : WC-0373

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-0016

    Start Marketing Date : 2019-11-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Levetiracetam

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Levetiracetam

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-12-16

    Pay. Date : 2015-09-23

    DMF Number : 28431

    Submission : 2014-06-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-275 - Rev 00

    Issue Date : 2020-12-09

    Type : Chemical

    Substance Number : 2535

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-08

    Valid Till : 2025-07-21

    Written Confirmation Number : WC-0373

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-0006

    Start Marketing Date : 2014-06-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Sumatriptan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Sumatriptan

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16279

    Submission : 2002-12-02

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-329 - Rev 05

    Issue Date : 2019-09-16

    Type : Chemical

    Substance Number : 1573

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 228MF10195

    Registrant's Address : Plot No. 72, H. No.:8-2-334/3&4 Road No. 5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad, Telangana, India

    Initial Date of Registration : 2016-10-11

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2019-06-26

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0071

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-5010

    Start Marketing Date : 2008-02-13

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Vardenafil Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Vardenafil Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 32908

    Submission : 2018-09-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-202 - Rev 01

    Issue Date : 2024-04-04

    Type : Chemical

    Substance Number : 2782

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-08

    Valid Till : 2025-07-21

    Written Confirmation Number : WC-0373

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-0014

    Start Marketing Date : 2018-03-20

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Itraconazole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Itraconazole

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-04-08

    Pay. Date : 2013-08-13

    DMF Number : 25514

    Submission : 2011-11-22

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2012-403 - Rev 01

    Issue Date : 2019-09-16

    Type : Chemical

    Substance Number : 1335

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-06-26

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0071

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-5043

    Start Marketing Date : 2011-06-15

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Ondansetron Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Ondansetron Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-08-28

    Pay. Date : 2013-08-19

    DMF Number : 22340

    Submission : 2008-12-23

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-319 - Rev 04

    Issue Date : 2019-09-16

    Type : Chemical

    Substance Number : 2016

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-06-26

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0071

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-5014

    Start Marketing Date : 2009-05-13

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Pantoprazole Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Pantoprazole Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22161

    Submission : 2008-11-10

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2008-262 - Rev 01

    Issue Date : 2024-10-14

    Type : Chemical

    Substance Number : 2296

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-08

    Valid Till : 2025-07-21

    Written Confirmation Number : WC-0373

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 67835-0007

    Start Marketing Date : 2015-03-04

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Almotriptan Malate

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    02

    Apixaban

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    03

    Aripiprazole

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    04

    Aripiprazole Usp

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    05

    Efavirenz Usp

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    06

    Eletriptan Hydrobromide Monohydrate

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    07

    Famotidine Usp

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    08

    Hydroxychloroquine Sulfate Usp

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    09

    Ibuprofen Sodium Dihydrate

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    10

    Ibuprofen Usp

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Aripiprazole

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    02

    Famotidine

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    03

    Famotidine, Unit-VII

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    04

    Ibuprofen, Hexanes route

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    05

    Ibuprofen, IPA route

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    06

    Itraconazole

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    07

    Itraconazole, Bachupally site

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    08

    Lamotrigine

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    09

    Levetiracetam

    CEP/COS

    Duphat
    Not Confirmed
    arrow

    10

    Ondansetron hydrochloride dihydrate

    CEP/COS

    Duphat
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    Duphat
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Duphat
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2011-02-04

    SMS Pharmaceuticals

    City : Ranga Reddy Dist., Hydera...

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2011-02-04

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    Duphat
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Duphat
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-04-18

    SMS Pharmaceuticals

    City : Ranga Reddy Dist., Hydera...

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-04-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    Duphat
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Duphat
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2012-07-27

    SMS Pharmaceuticals

    City : Andhra Pradesh

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2012-07-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact SMS Pharmaceuticals and get a quotation

    SMS Pharmaceuticals is a supplier offers 81 products (APIs, Excipients or Intermediates).

    Find a price of Famotidine bulk with DMF, CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Rizatriptan Benzoate bulk with DMF, CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Tadalafil bulk with DMF, CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Lamotrigine bulk with DMF, CEP, WC offered by SMS Pharmaceuticals

    Find a price of Levetiracetam bulk with DMF, CEP, WC offered by SMS Pharmaceuticals

    Find a price of Sumatriptan bulk with CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Vardenafil Hydrochloride bulk with DMF, CEP, WC offered by SMS Pharmaceuticals

    Find a price of Aripiprazole bulk with CEP, WC offered by SMS Pharmaceuticals

    Find a price of Itraconazole bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Pantoprazole Sodium bulk with CEP, WC offered by SMS Pharmaceuticals

    Find a price of Ranitidine Hydrochloride bulk with CEP, WC offered by SMS Pharmaceuticals

    Find a price of Apixaban bulk with DMF, WC offered by SMS Pharmaceuticals

    Find a price of Efavirenz bulk with DMF, WC offered by SMS Pharmaceuticals

    Find a price of Famotidine bulk with CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Ibuprofen bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Pantoprazole Sodium bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Sildenafil Citrate bulk with CEP offered by SMS Pharmaceuticals

    Find a price of Solifenacin Succinate bulk with DMF, WC offered by SMS Pharmaceuticals

    Find a price of Almotriptan Malate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Imidapril Hydrochloride bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Rosiglitazone Maleate bulk with WC offered by SMS Pharmaceuticals

    Find a price of Zolmitriptan bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Aripiprazole bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Eletriptan Hydrobromide Monohydrate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Hydroxychloroquine Sulphate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Ibuprofen bulk with CEP offered by SMS Pharmaceuticals

    Find a price of Ibuprofen Sodium bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Lamivudine bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Lanoconazole bulk with JDMF offered by SMS Pharmaceuticals

    Find a price of Lopinavir bulk with WC offered by SMS Pharmaceuticals

    Find a price of Luliconazole bulk with WC offered by SMS Pharmaceuticals

    Find a price of Molnupiravir bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Paliperidone Palmitate bulk with WC offered by SMS Pharmaceuticals

    Find a price of Penciclovir bulk with WC offered by SMS Pharmaceuticals

    Find a price of Penciclovir Sodium bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Pirfenidone bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Ramipril bulk offered by SMS Pharmaceuticals

    Find a price of Ranitidine Hydrochloride bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Ranitidine Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Ranolazine bulk with WC offered by SMS Pharmaceuticals

    Find a price of Rivaroxaban bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Rosiglitazone Maleate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Sildenafil Citrate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Sitagliptin Hydrochloride bulk with WC offered by SMS Pharmaceuticals

    Find a price of Sumatriptan bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Sumatriptan bulk offered by SMS Pharmaceuticals

    Find a price of Tenofovir Disoproxil Fumarate bulk with WC offered by SMS Pharmaceuticals

    Find a price of Vildagliptin bulk with WC offered by SMS Pharmaceuticals

    Find a price of CLOZAPINE USP bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Apixaban bulk offered by SMS Pharmaceuticals

    Find a price of Eletriptan Hydrobromide bulk offered by SMS Pharmaceuticals

    Find a price of Itraconazole bulk offered by SMS Pharmaceuticals

    Find a price of Lansoprazole bulk offered by SMS Pharmaceuticals

    Find a price of Nicotine bulk offered by SMS Pharmaceuticals

    Find a price of Vardenafil Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Brexpiprazole bulk offered by SMS Pharmaceuticals

    Find a price of Brivaracetam bulk offered by SMS Pharmaceuticals

    Find a price of Canagliflozin bulk offered by SMS Pharmaceuticals

    Find a price of Clozapine bulk offered by SMS Pharmaceuticals

    Find a price of Dabigatran Etexilate Mesylate bulk offered by SMS Pharmaceuticals

    Find a price of Dapagliflozin bulk offered by SMS Pharmaceuticals

    Find a price of Deferasirox bulk offered by SMS Pharmaceuticals

    Find a price of Dolutegravir Sodium bulk offered by SMS Pharmaceuticals

    Find a price of Elagolix Sodium bulk offered by SMS Pharmaceuticals

    Find a price of Empagliflozin bulk offered by SMS Pharmaceuticals

    Find a price of Ezetimibe bulk offered by SMS Pharmaceuticals

    Find a price of Lacosamide bulk offered by SMS Pharmaceuticals

    Find a price of Linagliptin bulk offered by SMS Pharmaceuticals

    Find a price of Macitentan bulk offered by SMS Pharmaceuticals

    Find a price of Mirabegron bulk offered by SMS Pharmaceuticals

    Find a price of Perampanel bulk offered by SMS Pharmaceuticals

    Find a price of Pimavanserin Tartrate bulk offered by SMS Pharmaceuticals

    Find a price of Raltegravir Potassium bulk offered by SMS Pharmaceuticals

    Find a price of Ramelteon bulk offered by SMS Pharmaceuticals

    Find a price of Rifaximin bulk offered by SMS Pharmaceuticals

    Find a price of Sitagliptin Phosphate bulk offered by SMS Pharmaceuticals

    Find a price of Tenofovir Alafenamide Fumarate bulk offered by SMS Pharmaceuticals

    Find a price of Ticagrelor bulk offered by SMS Pharmaceuticals

    Find a price of Valacyclovir bulk offered by SMS Pharmaceuticals

    Find a price of Vigabatrin bulk offered by SMS Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search